Compare Pharma Foods International Co., Ltd. with Similar Stocks
Dashboard
1
With a fall in Net Sales of -14.81%, the company declared Very Negative results in Oct 25
- The company has declared negative results for the last 4 consecutive quarters
- INTEREST(HY) At JPY 48 MM has Grown at 14.29%
- OPERATING CASH FLOW(Y) Lowest at JPY -3,243 MM
- ROCE(HY) Lowest at -18.06%
2
Risky -
3
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
JPY 20,065 Million (Small Cap)
10.00
NA
0.00%
0.67
-19.37%
2.14
Revenue and Profits:
Net Sales:
15,712 Million
(Quarterly Results - Oct 2025)
Net Profit:
-1,891 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.89%
0%
-7.89%
6 Months
-28.11%
0%
-28.11%
1 Year
-30.68%
0%
-30.68%
2 Years
-34.7%
0%
-34.7%
3 Years
-56.59%
0%
-56.59%
4 Years
-66.7%
0%
-66.7%
5 Years
-78.66%
0%
-78.66%
Pharma Foods International Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
38.61%
EBIT Growth (5y)
52.95%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
1.10
Net Debt to Equity (avg)
0.11
Sales to Capital Employed (avg)
2.41
Tax Ratio
85.60%
Dividend Payout Ratio
195.26%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
39.70%
ROE (avg)
35.86%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
2.34
EV to EBIT
7.02
EV to EBITDA
5.71
EV to Capital Employed
2.20
EV to Sales
0.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
31.39%
ROE (Latest)
22.89%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Oct'25 - QoQ
Oct'25
Jul'25
Change(%)
Net Sales
15,712.00
18,443.00
-14.81%
Operating Profit (PBDIT) excl Other Income
-2,345.00
2,801.00
-183.72%
Interest
25.00
23.00
8.70%
Exceptional Items
0.00
-118.00
100.00%
Consolidate Net Profit
-1,891.00
1,491.00
-226.83%
Operating Profit Margin (Excl OI)
-159.80%
140.20%
-30.00%
USD in Million.
Net Sales
QoQ Growth in quarter ended Oct 2025 is -14.81% vs 8.74% in Jul 2025
Consolidated Net Profit
QoQ Growth in quarter ended Oct 2025 is -226.83% vs 210.28% in Jul 2025
Annual Results Snapshot (Consolidated) - Jul'25
Jul'25
Jul'24
Change(%)
Net Sales
65,260.00
62,147.00
5.01%
Operating Profit (PBDIT) excl Other Income
3,154.00
6,021.00
-47.62%
Interest
91.00
62.00
46.77%
Exceptional Items
-118.00
-123.00
4.07%
Consolidate Net Profit
368.00
3,205.00
-88.52%
Operating Profit Margin (Excl OI)
36.30%
82.30%
-4.60%
USD in Million.
Net Sales
YoY Growth in year ended Jul 2025 is 5.01% vs -9.37% in Jul 2024
Consolidated Net Profit
YoY Growth in year ended Jul 2025 is -88.52% vs 4.06% in Jul 2024
About Pharma Foods International Co., Ltd. 
Pharma Foods International Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






